Mahaney Paige bought CCCC
February 14, 2025 · Form 4 insider transaction
Mahaney Paige bought 42,400 shares of C4 Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,400
Price
$0.00
Total value
N/A
InsiderMahaney Paige
RoleOfficer
CompanyC4 Therapeutics, Inc. (CCCC)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 14, 2025
Filing dateFebruary 18, 2025
Shares owned after42,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025.